ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
Organogenesis Holdings Inc (ORGO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+26.9%
Last 4 quarters
Revenue YoY growth
+78.1%
Most recent quarter
EPS YoY growth
+504.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+10.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+41.8%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $0.40 | +85.5% | $4.11 | $3.21 | -21.9% |
| 2025-11-06 | $0.12 | +95.1% | $3.97 | $5.63 | +41.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.22 | $0.40 | +85.5% | $225.61M | +78.1% |
| 2025-09-30 | $0.06 | $0.12 | +95.1% | $150.86M | +31.0% |
| 2025-06-30 | $-0.05 | $-0.10 | -100.0% | $100.78M | -22.6% |
| 2025-03-31 | $-0.04 | $-0.17 | -325.0% | $86.69M | -21.2% |
| 2024-12-31 | $0.02 | $0.07 | +231.0% | $126.66M | +27.1% |
| 2024-09-30 | $-0.01 | $0.10 | +1066.0% | $115.18M | +6.1% |
| 2024-06-30 | $-0.01 | $0.04 | +500.0% | $130.23M | +11.0% |
| 2024-03-31 | $-0.03 | $-0.02 | +33.3% | $109.98M | +2.2% |
| 2023-12-31 | $0.01 | $-0.00 | -143.0% | $99.65M | — |
| 2023-09-30 | $0.01 | $0.02 | +100.0% | $108.53M | — |
| 2023-06-30 | $0.03 | $0.04 | +33.3% | $117.32M | — |
| 2023-03-31 | $-0.02 | $-0.02 | +0.0% | $107.64M | — |
Frequently asked questions
Has Organogenesis Holdings Inc beaten earnings estimates?
Organogenesis Holdings Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +26.9% over the last 3 quarters.
How does ORGO stock react to earnings?
ORGO stock has moved an average of +10.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Organogenesis Holdings Inc's revenue growth rate?
Organogenesis Holdings Inc reported year-over-year revenue growth of +78.1% in its most recent quarter, with EPS growing +504.4% year-over-year.